Trade Gilead GILD

Sell
 Buy

Gilead live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

Gilead News

Emma Rose 2025 Nov 22, 00:00

Citadel Securities' Rubner: S&P 500's 'Healthy' Pullback Sets Stage for Year-End Rally

Sophia Claire 2025 Nov 22, 00:00

Ray Dalio: Why You Shouldn't Abandon AI Despite Bubble Concerns

Emma Rose 2025 Nov 21, 00:00

US Nonfarm Payrolls: September's Delayed Report and Fed Rate Hike Speculation

Ava Grace 2025 Nov 21, 00:00

US Repo Market Liquidity Concerns Linger Despite Fed Easing

Frances Wang 2025 Nov 20, 16:00

AI stock analysis: BBAI stock slides 5% today, what happened to BigBear.ai?

Frances Wang 2025 Nov 20, 16:00

Gold price XAUUSD analysis: XAU/USD remains neutral, what’s next?

Ghko B 2025 Nov 19, 16:00

Best AI Stocks to Buy 2026: CoreWeave (CRWV) Stock, Nvidia (NVDA), AVGO

Frances Wang 2025 Nov 19, 16:00

XRP price forecast: XRP price keeps falling, is XRP expected to go up?

Frances Wang 2025 Nov 18, 16:00

BTC/USD prediction: Bitcoin dips below $92K, will bitcoin bounce back?

Noah Lee 2025 Nov 10, 09:10

x402 Ecosystem Competition Analysis: Launchpads, Facilitators, and Providers

Latest news

Show more
Emma Rose 2025 Nov 23, 03:10

Crypto Lending Markets Q3 2025 Analysis: A Deep Dive

Sophia Claire 2025 Nov 23, 01:50

Bitcoin Market Correction: Defensive Trading Strategies Amidst Weakness

Sophia Claire 2025 Nov 23, 01:10

BlackRock: Bitcoin Payment Use Still Speculative, Stablecoins Scaling Faster

Noah Lee 2025 Nov 23, 00:00

Market Review and Investment Strategy Insights - 2024

Sophia Claire 2025 Nov 22, 22:20

Bitcoin Transfer from OGs to Weak Hands: Analyzing the Market Impact

Ava Grace 2025 Nov 22, 20:50

Cardano Network Split Sparks FBI Investigation After AI-Fueled Glitch

Noah Lee 2025 Nov 22, 16:50

Coinbase Initiates Large Fund Migration: A Routine Security Measure

Sophia Claire 2025 Nov 22, 14:40

Market Review and Week Ahead Outlook: Gold, Oil, Stocks & Crypto in Focus

Info

Spread

0.84

Spread (%)

0.6655 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

14:31 - 20:59

Tuesday

14:31-20:59

Wednesday

14:31-20:59

Thursday

14:31-20:59

Friday

14:31-20:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

157135781888

Shares Outstanding

1240679623

Earnings Date (Next)

2013-01-28

Div Yield

2025-12-30

Ex-Dividend Date

2025-12-15

Forward annual dividend rate

3.16

Forward annual dividend yield

0.025

EPS

6.46

Learn more about this instrument

Gilead Gilead Sciences Inc
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; Marengo Therapeutics; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Ghko B 2025 Nov 20, 16:00

What Are Privacy Coins: Top 3 Privacy Coins, Do Privacy Coins Have a Future?

Ghko B 2025 Nov 20, 16:00

CFD Trading Explained: Understanding the Basics and Benefits of CFD

Ghko B 2025 Nov 20, 16:00

10 Best Ways to trade Cryptos as Beginner: How to Make Money with Cryptos?

Trustpilot